About Osel
Osel is the leading company in the emerging field of Bacterial Therapeutics. Our business is based upon commercializing pharmaceutical products utilizing naturally occurring bacteria in the maintenance of health and the prevention of disease.
Osel's Mission
Osel’s mission is to harness the therapeutic properties of non-pathogenic bacteria as the basis for a series of innovative products targeted for the prevention and treatment of diseases of the genitourinary and gastrointestinal tracts, initially to service the U.S. and European marketplaces. Due to the relatively short clinical trial duration (approximately 4 months), Osel expects to expedite bringing its product candidates to a potential Market of some $10 billion. Osel is also developing second generation bacterial products that have been genetically enhanced to improve their disease fighting capabilities.
